This piece mentions Thirdwave Technologies (NASDAQ:TWTI)
http://www.c3ktogo.com/news-video/?mgid=14318
MTWTI has a market cap = US$400m and currently trading at 5 year highs.
Deutshe Bank this week initiated research coverage with a Strong Buy recommendation.
TWT has 2 HPV tests, a high risk HPV test and a Type 16 & 18 HPV genotyping test. Types 16 & 18 cause 70% of all cervical cancers. There are another 12 types that cause the other 30% of cervical cancers.
GBI's test detects AND genotypes ALL 14 high risk types (ie. it specifies the other 12 risk types that cause 30% of all cervical cancers as well!)
If you were a woman which test would you want?
One that genotypes 70% of the HPV types that cause cervical cancer or one that genotypes 100%?
If GBI can even be half the market cp of TWTI = $2.10 per share...all aboard!
- Forums
- ASX - By Stock
- tv segment on the need for hpv testing
This piece mentions Thirdwave Technologies...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GBI (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online